Bath & Body Works (NYSE:BBWI – Get Free Report) is one of 27 public companies in the “Retail stores, not elsewhere classified” industry, but how does it compare to its rivals? We will compare Bath & Body Works to related companies based on the strength of its institutional ownership, dividends, risk, valuation, analyst recommendations, profitability and earnings.
Volatility & Risk
Bath & Body Works has a beta of 1.83, meaning that its share price is 83% more volatile than the S&P 500. Comparatively, Bath & Body Works’ rivals have a beta of 0.81, meaning that their average share price is 19% less volatile than the S&P 500.
Profitability
This table compares Bath & Body Works and its rivals’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Bath & Body Works | 12.43% | -44.03% | 14.45% |
Bath & Body Works Competitors | -21.34% | -60.07% | 0.73% |
Dividends
Valuation and Earnings
This table compares Bath & Body Works and its rivals top-line revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Bath & Body Works | $7.43 billion | $878.00 million | 9.58 |
Bath & Body Works Competitors | $49.00 billion | $153.49 million | -4.93 |
Bath & Body Works’ rivals have higher revenue, but lower earnings than Bath & Body Works. Bath & Body Works is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.
Institutional & Insider Ownership
95.1% of Bath & Body Works shares are owned by institutional investors. Comparatively, 33.7% of shares of all “Retail stores, not elsewhere classified” companies are owned by institutional investors. 0.3% of Bath & Body Works shares are owned by insiders. Comparatively, 15.7% of shares of all “Retail stores, not elsewhere classified” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current ratings and target prices for Bath & Body Works and its rivals, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Bath & Body Works | 1 | 6 | 9 | 0 | 2.50 |
Bath & Body Works Competitors | 96 | 875 | 1512 | 62 | 2.61 |
Bath & Body Works currently has a consensus target price of $42.50, suggesting a potential upside of 8.23%. As a group, “Retail stores, not elsewhere classified” companies have a potential upside of 9.10%. Given Bath & Body Works’ rivals stronger consensus rating and higher probable upside, analysts clearly believe Bath & Body Works has less favorable growth aspects than its rivals.
Summary
Bath & Body Works beats its rivals on 8 of the 15 factors compared.
About Bath & Body Works
Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements. The company was formerly known as L Brands, Inc. and changed its name to Bath & Body Works, Inc. in August 2021. Bath & Body Works, Inc. was founded in 1963 and is headquartered in Columbus, Ohio.
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.